NVAX -- Crazy climb!! In try to finding vaccine....

NVAX -- Crazy climb!! In a try to reach a vaccine.... ZACKS pick The company’s expected earnings growth rate for the current year is 46% compared with the Zacks Medical - Biomedical and Genetics industry’s projected earnings growth of 8.1%. Novavax, Inc. NVAX is a late-stage biotechnology company that focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Post the virus outbreak, the company has launched a program for the coronavirus vaccine. Novavax already boasts success in vaccine development for the MERS and SARS strains.

Be careful with Pharmicuticals... can be great BUT can reverse VERY VERY quickly. Buy moderate lows. Can be shorted because of this.

SPIKING ON NEWS!! TODAY.

___________________________________

Disclaimer:
Always do your own due diligence, full research, and homework, and consult with your own licensed investment professional before any investments. Any comments and analysis seen here are personal opinions, and we are not registered or licensed in any jurisdiction whatsoever to provide any investing advice. Any analysis, charting and comments should never be used for the purposes of assisting in any advisory decisions with any stock purchase or sale, and never to be used on the basis of making any kind of investment decisions. It is for the sole purposes of opinions and thoughts only of the markets. Thank you.





Technical IndicatorsTrend Analysis

Penafian